137 related articles for article (PubMed ID: 15944010)
1. Role of galanin and galanin(1-15) on central cardiovascular control.
Díaz-Cabiale Z; Parrado C; Vela C; Razani H; Coveñas R; Fuxe K; Narváez JA
Neuropeptides; 2005 Jun; 39(3):185-90. PubMed ID: 15944010
[TBL] [Abstract][Full Text] [Related]
2. Intracisternal galanin/angiotensin II interactions in central cardiovascular control.
Díaz-Cabiale Z; Parrado C; Vela C; Coveñas R; Yanaihara N; Fuxe K; González-Barón S; Narváez JA
Regul Pept; 2005 Apr; 127(1-3):133-40. PubMed ID: 15680479
[TBL] [Abstract][Full Text] [Related]
3. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
4. The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15).
Narváez JA; Díaz-Cabiale Z; Hedlund PB; Aguirre JA; Coveñas R; González-Barón S; Fuxe K
Eur J Pharmacol; 2000 Jul; 399(2-3):197-203. PubMed ID: 10884520
[TBL] [Abstract][Full Text] [Related]
5. Central galanin and N-terminal galanin fragment induce c-Fos immunoreactivity in the medulla oblongata of the anesthetized rat.
Marcos P; Díaz-Cabiale Z; Cordón MP; Coveñas R; Yanaihara N; Fuxe K; González-Barón S; Narváez JA
Peptides; 2001 Sep; 22(9):1501-9. PubMed ID: 11514035
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological manipulation of brain galaninergic system and sexual behavior in male mice.
Benelli A; Bertolini A; Zoli M; Leo G; Filaferro M; Saltini S; Genedani S
Psychopharmacology (Berl); 2002 Mar; 160(3):325-30. PubMed ID: 11889502
[TBL] [Abstract][Full Text] [Related]
7. Effects of intracerebroventricular losartan on angiotensin II-mediated pressor responses and c-fos expression in near-term ovine fetus.
Shi L; Mao C; Thornton SN; Sun W; Wu J; Yao J; Xu Z
J Comp Neurol; 2005 Dec; 493(4):571-9. PubMed ID: 16304626
[TBL] [Abstract][Full Text] [Related]
8. Galanin/alpha2-receptor interactions in central cardiovascular control.
Díaz-Cabiale Z; Narváez JA; Yanaihara N; González-Barón S; Fuxe K
Neuropharmacology; 2000 Jun; 39(8):1377-85. PubMed ID: 10818254
[TBL] [Abstract][Full Text] [Related]
9. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease.
Lang R; Gundlach AL; Kofler B
Pharmacol Ther; 2007 Aug; 115(2):177-207. PubMed ID: 17604107
[TBL] [Abstract][Full Text] [Related]
10. Galanin and NH2-terminal galanin fragments in central cardiovascular regulation.
Díaz-Cabiale Z; Narváez JA; Marcos P; Cordón MP; Coveñas R; Fuxe K; González-Baron S
Ann N Y Acad Sci; 1998 Dec; 863():421-4. PubMed ID: 9928189
[No Abstract] [Full Text] [Related]
11. Inhibitory effects of different galanin compounds and fragments on osmotically and histamine-induced enhanced vasopressin secretion in rats.
Molnár A; Baláspiri L; Gálfi M; László F; Varga C; Berkó A; László FA
Eur J Pharmacol; 2005 Jun; 516(2):174-9. PubMed ID: 15925363
[TBL] [Abstract][Full Text] [Related]
12. Administration of the galanin antagonist M40 into lateral septum attenuates shock probe defensive burying behavior in rats.
Echevarria DJ; Hernandez A; Diogenes A; Morilak DA
Neuropeptides; 2005 Oct; 39(5):445-51. PubMed ID: 16084587
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular administration of galanin or galanin receptor subtype 1 agonist M617 induces c-Fos activation in central amygdala and dorsomedial hypothalamus.
Blackshear A; Yamamoto M; Anderson BJ; Holmes PV; Lundström L; Langel U; Robinson JK
Peptides; 2007 May; 28(5):1120-4. PubMed ID: 17337094
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical modulation of central cardiovascular control: the integrative role of galanin.
Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA
Exp Suppl; 2010; 102():113-31. PubMed ID: 21299065
[TBL] [Abstract][Full Text] [Related]
15. Galanin inhibits calcium channels via Galpha(i)-protein mediated by GalR1 in rat nucleus tractus solitarius.
Endoh T; Sato D; Wada Y; Shibukawa Y; Ishihara K; Hashimoto S; Yoshinari M; Matsuzaka K; Tazaki M; Inoue T
Brain Res; 2008 Sep; 1229():37-46. PubMed ID: 18602374
[TBL] [Abstract][Full Text] [Related]
16. [The central exciting role of galanin antagonist M40 at low concentration].
Shi MY; Chen Q; Wu YD
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Aug; 18(3):238, 248, 256. PubMed ID: 21180059
[No Abstract] [Full Text] [Related]
17. Galanin function in the central nervous system.
Walton KM; Chin JE; Duplantier AJ; Mather RJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):560-70. PubMed ID: 17002216
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress.
Khoshbouei H; Cecchi M; Morilak DA
Neuropsychopharmacology; 2002 Jul; 27(1):25-34. PubMed ID: 12062904
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists.
Lang R; Berger A; Santic R; Geisberger R; Hermann A; Herzog H; Kofler B
Neuropeptides; 2005 Jun; 39(3):179-84. PubMed ID: 15944009
[TBL] [Abstract][Full Text] [Related]
20. Central injection of galanin inhibits angiotensin II-induced responses in rats.
Hirase M; Ono K; Yamashita H; Inenaga K
Neuroreport; 2008 Feb; 19(3):323-6. PubMed ID: 18303575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
